Abstract:Background: RNA-binding proteins (RBPs) play a crucial role in regulating RNA turnover and are associated with cancer development. However, little is known about the role of RBPs in esophageal cancer (ESCA). The present study focuses on the association between RBP gene expression and survival in ESCA, addressing the clinical relevance of an RBPs-based prediction model for prognosis. Methods: RNA-sequencing data and clinical information of patients with ESCA were obtained from The Cancer Genome Atlas (TCGA) database. We identified differentially expressed genes in ESCA and intersected them with RBP-encoding genes. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed with the identified differentially expressed RBPs. Then, a protein-protein interaction (PPI) network was constructed through the STRING database to determine the hub RBPs. Univariate Cox regression analysis and multivariate Cox regression analysis were applied to construct a novel prognostic model based on RBPs. Based on the R package "Caret", we divided patients into the training set and validation set. The efficacy of the prognostic model was evaluated by the area under the receiver operating characteristic (ROC) curve. A nomogram was developed for the prediction of patient survival outcomes. Results: A total of 158 ESCA patients from the TCGA database were included in our analysis. We screened out five prognostic RBPs (CLK1, CIRBP, MRPL13, TNRC6A, and TYW3) through univariate and multivariate Cox regression analysis. CLK1, CIRBP, TNRC6A and TYW3 were downregulated in tumor samples, while MRPL13 was upregulated. A prognostic model constructed with these five RBPs in the training data set accurately stratified ESCA patients into high- and low-risk groups. When the same prognostic model was applied to the test data set and entire cohort, the 5-RBP signature remained an independent prognostic factor in multivariate analysis. The areas under the time-dependent ROC curve of the prognostic model for predicting one-year survival in the training data set, test data set, and entire cohort were 0.789, 0.753, and 0.764, respectively, confirming that this model is a good prognostic model. The nomogram based on the five RBPs and clinical variables could improve individualized outcome predictions and highlight the importance of RBPs in the outcomes of patients with ESCA. Conclusions: Our study provides a potential prognostic model for predicting the prognosis of ESCA patients. The prognostic nomogram could improve individualized outcome predictions for patients with ESCA, therefore providing novel insights into future diagnosis and treatment.

The construction and validation of an RNA binding protein-related prognostic model for bladder cancer

Construction and validation of a prognostic model of RNA binding proteins in clear cell renal carcinoma

Transcriptome Analyses Identify an RNA Binding Protein Related Prognostic Model for Clear Cell Renal Cell Carcinoma

Identification of the Functions and Prognostic Values of RNA Binding Proteins in Bladder Cancer

Development and Validation of a RNA Binding Protein-Associated Prognostic Model for Hepatocellular Carcinoma

Integrated Analysis and Identification of Critical RNA-Binding Proteins in Bladder Cancer

Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer

Development and Validation of a RNA Binding Protein-Associated Prognostic Model for Lung Adenocarcinoma

Development and validation of a prognostic model based on RNA binding proteins in patients with esophageal cancer

Development and Validation of an RNA Binding Protein-associated Prognostic Model for Hepatocellular Carcinoma.

Construction and Verification of an RNA-Binding Protein-Associated Prognostic Model for Gliomas

Construction of an RNA-Binding Protein-Related Prognostic Model for Pancreatic Adenocarcinoma Based on TCGA and GTEx Databases

Construction and validation of a prognostic model for esophageal cancer based on prognostic-related RNA-binding protein

A novel RNA binding protein-associated prognostic model to predict overall survival in hepatocellular carcinoma patients

Development and Validation of a Prediction Model for Lung Adenocarcinoma Based on RNA-binding Protein

A Prognostic Model Based on RNA Binding Protein Predicts Clinical Outcomes in Hepatocellular Carcinoma Patients

A Four-Gene Model for Prognostic Prediction in Bladder Urothelial Carcinoma

Development of prognostic signature based on RNA binding proteins related genes analysis in clear cell renal cell carcinoma

Integrated Analysis of the Roles of RNA Binding Proteins and Their Prognostic Value in Clear Cell Renal Cell Carcinoma

Identification and Validation of an RNA Binding Proteins-Associated Prognostic Signature for Non-Small Cell Lung Cancer